Insmed vs Liquidia
INSM and LQDA side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How INSM and LQDA compare
Insmed is the larger company, worth 5.3 times as much as Liquidia ($26.7B against $5.1B).
Liquidia grew revenue faster over the last twelve months (2234% versus 240% for Insmed).
Liquidia keeps more of each dollar of sales as profit, with a net margin of 30.7% compared with −39.9% at Insmed.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | INSM | LQDA |
|---|---|---|
| Size and price | ||
| Market cap | $26.7B | $5.1B |
| Share price | $121.86 | $56.73 |
| Change, 1 year | −36.9% | 102% |
| Change, 5 years | 321% | 1280% |
| Beta (5Y) | 0.84 | 1.00 |
| Employees | 1,664 | 216 |
| StockData Score | ||
| Total score | 8 | 8 |
| Valuation score | 0 | 0 |
| Growth score | 3 (better) | 2 |
| Performance score | 2 | 3 (better) |
| Health score | 3 | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 40.8× |
| P/S | 17.6× | 11.3× (better) |
| P/B | 36.8× | 26.0× (better) |
| EV/EBITDA | – | 28.2× |
| P/FCF | – | 33.7× |
| FCF yield | −2.3% | 3.0% (better) |
| Fair value | $61.10 | $32.46 |
| Margin of safety | −99.5% | −74.8% (better) |
| Growth | ||
| Revenue growth (TTM) | 240% | 2234% (better) |
| Revenue growth, 5Y average | 29.8% | 192% (better) |
| Profitability | ||
| Gross margin | 84.4% | – |
| Operating margin | −37.1% | 37.4% (better) |
| Net margin | −39.9% | 30.7% (better) |
| FCF margin | −41.3% | 33.4% (better) |
| Return on equity | −72.5% | 132% (better) |
| Financial health | ||
| Debt / equity | 0.76 | – |
| Interest coverage | −6.9× | 6.3× (better) |
| Current ratio | 2.86 (better) | 2.31 |
| Altman Z-score | 7.42 | 10.49 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 102% | 81.1% |
| Held by insiders | 0.89% | 19.5% |
| Insider net buying, 12 months | −$133M (better) | −$227M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 6.5% | 24.3% |
Go deeper
- INSM stock overview
- INSM income statement
- INSM valuation and score
- LQDA stock overview
- LQDA income statement
- LQDA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.